Zydus’ US subsidiary receives FDA approval for Menkes disease
Ahmedabad: Zydus Lifesciences US based subsidiary, Sentynl Therapeutics, has received US FDA’s approval for its ZYCUBO® drug aimed at treating the rare genetic Menkes disease that affects children. This is...
